Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 Loss of 34c/Share
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
Interest and other income/ (expense), net: 115K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Interest and other income/ (expense), net: 115K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q2 EPS of ($0.34), $0.33 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.24 million.
For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
- Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
